Objective To evaluate the association between dietary inflammatory index (DII) scores during pregnancy and neonatal adiposity.
Results
The interaction between prepregnancy BMI and DII was statistically significant for birth weight, neonatal fat mass, and neonatal percent fat mass. Among neonates born to obese women, each 1-unit increase in DII was associated with increased birth weight (53 g; 95% CI, 20, 87), fat mass (20 g; 95% CI, , and percent fat mass (0.5%; 95% CI, 0.2-0.8). No interaction was detected for small-and large-for-gestational age. Each 1-unit increase in DII score was associated a 40% increase in odds of a large-for-gestational age neonate (1.4; 95% CI, 1.0-2.0; P = .04), but not a small-for-gestational age neonate (1.0; 95% CI, 0.8-1.2; P = .80). There was no evidence of an interaction with gestational weight gain.
Conclusions Our findings support the hypothesis that an increased inflammatory milieu during pregnancy may be a risk factor for neonatal adiposity. (J Pediatr 2018;195:121-7).
Trial registration Clinicaltrials.gov: NCT02273297.
See editorial, p 9 and related article, p 275 F uture risk for obesity may manifest as early as 2 months of age, 1 which suggests that intrauterine exposures may predispose offspring to obesity. 2 An inflammatory milieu during pregnancy can result in fetal overgrowth. [3] [4] [5] [6] In both human and animal pregnancies, exposure to inflammatory cytokines is associated with increased adiposity in offspring. 5, 6 Prepregnancy obesity is an important contributing factor to neonatal adiposity and maternal subclinical inflammation may be a key mechanism. [7] [8] [9] [10] Obesity is characterized by chronic, low-grade inflammation that is further exacerbated by metabolic changes during pregnancy. 11, 12 Fetuses from obese women are exposed to a proinflammatory environment during development, 4, [12] [13] [14] [15] which may be associated with increased adiposity at birth. 16 Excessive gestational weight gain may also contribute to inflammation via maternal fat accumulation. 17 A proinflammatory diet during pregnancy may alter the risk for neonatal adiposity, especially in the context of preexistent maternal obesity or excessive gestational weight gain. The dietary inflammatory index (DII) is an indicator of the overall inflammatory potential of an individual's diet. 18 The DII ranges from −9 (most anti-inflammatory) to +8 (most proinflammatory), 18 where higher DII scores ASA24 Automated Self-Administered 24-hour Dietary Recall BMI Body mass index CRP-hs High-sensitivity C-reactive protein DII Dietary inflammatory index IL Interleukin are associated with increased circulation of inflammatory markers. [19] [20] [21] Higher DII scores may indicate a diet high in the consumption of processed meat and sugar-sweetened beverages, whereas lower DII scores may indicate a diet with ample servings of fruit, vegetables, whole grains, fish, and eggs. 20 Sen et al demonstrated that higher DII scores among women who were obese entering pregnancy is associated with an increase in odds of a small-for-gestational age neonate. 20 However, the impact of DII scores on neonatal adiposity is unknown.
Our goal was to evaluate the association between DII scores during pregnancy and neonatal adiposity, incorporating a direct measure of body composition. We hypothesized that a higher DII score would be associated with greater adiposity at birth, particularly among neonates born to obese mothers or mothers with excessive gestational weight gain.
Methods
The Healthy Start study recruited 1410 pregnant women aged ≥16 years with singleton pregnancies enrolled before 24 weeks of gestation from the obstetrics clinics at the University of Colorado Hospital from 2009 through 2014. Participants completed research visits in early pregnancy (median 17 weeks of gestation), mid-pregnancy (median 27 weeks of gestation), and at delivery (median 1 day after delivery). Additional inclusion criteria for this study included completion of ≥1 dietary recall, neonates born ≥32 weeks of gestation, those with complete body composition measures at birth, and those born to women with a prepregnancy body mass index (BMI) of ≥18.5 kg/m 2 . The Healthy Start study protocol was approved by the Colorado Multiple Institutional Review Board. All women provided written informed consent before the first study visit. The Healthy Start study was registered as an observational study at clinicaltrials.gov as NCT02273297.
Fat mass and fat-free mass were measured using air displacement plethysmography (PEA POD, COSMED, Rome Italy) within approximately 72 hours of delivery. The PEA POD device measures body mass and volume, calculates body density, and estimates fat mass (g), fat-free mass (g), and percent fat mass. Each neonate was measured twice by trained research personnel, with a third measurement taken when percent fat mass differed by >2.0%. The average of the 2 closest readings was used for analysis.
We calculated sex-specific percentiles of birth weight for gestational age by using United States national reference data. 22 Neonatal size was defined as follows: small-for-gestational age (birth weight <10th percentile for age and sex), appropriatefor-gestational age (birth weight ≥10th percentile, and ≤90 th percentile for age and sex), and large-for-gestational age (birth weight >90th percentile for age and sex). For this analysis, appropriate-for-gestational age served as the reference category.
Maternal diet was measured throughout pregnancy using the Automated Self-Administered 24-hour Dietary Recall (ASA24), an online platform developed and hosted by the National Cancer Institute (ASA24-Beta and ASA24-2011, Bethesda, Maryland). Healthy Start participants were asked to complete 1 dietary recall per month, beginning at the first study visit. Approximately 76% of the participants completed ≥2 dietary recalls over the pregnancy period (range, 1-8; median, 3). Trained, bilingual study staff members administered recalls in-person for Spanish-speaking participants (n = 60) at study visits and over the phone between research visits. Data from the ASA24 were collected and processed by the Diet, Physical Activity and Body Composition Core of the Nutrition Obesity Research Center at the University of North Carolina at Chapel Hill. Individual nutrients were derived from the recalls using the US Department of Agriculture Food and Nutrient Database for Dietary Studies, versions 1.0 and 4.1.
The DII scores were based on 28 nutrients obtained from the 24-hour dietary recalls 18 : energy, total fat, saturated fat, monounsaturated fat, polyunsaturated fat, omega-3 polyunsaturated fatty acids, omega-6 fatty acids, trans-fat, carbohydrates, fiber, protein, cholesterol, iron, vitamin A, vitamin C, vitamin D, vitamin E, niacin, thiamin, riboflavin, vitamin B6, vitamin B12, folic acid, magnesium, zinc, selenium, alcohol, and caffeine. Inflammatory effect scores were computed for each of the 28 nutrients based on approximately 6500 peer-reviewed articles (Figure 1 ; available at www.jpeds.com). Inflammatory effect scores were derived by first assigning "+1" to antiinflammatory nutrients and "-1" to proinflammatory nutrients and then adjusting the scores by the total number of articles that cited its proinflammatory or anti-inflammatory effects. The inflammatory effect scores indicate the relative contribution of each nutrient to the final DII score, where fiber is the most anti-inflammatory nutrient and saturated fat is the most proinflammatory nutrient.
The DII score for each dietary recall was obtained by standardizing the nutrient intakes to global means, multiplying by the appropriate inflammatory effect scores, and taking the sum of the 28 nutrients. 18 For women with >1 dietary recall, the DII scores were averaged across the entire pregnancy.
Maternal height was measured using a stadiometer at the first research visit by research personnel. Prepregnancy weight was obtained from medical records (91%) or from questionnaires completed at the early pregnancy research visit (9%). Previous studies have reported strong agreement between selfreported prepregnancy weight and prepregnancy weights obtained from medical records or study data. 23, 24 Prepregnancy BMI was calculated as prepregnancy weight (kg) divided by height (m) squared. Prepregnancy BMI categories were defined as follows: lean (BMI of >18.5 kg/m 2 and <25 kg/m 2 ), overweight (BMI of ≥25 kg/m 2 and <30 kg/m 2 ), and obese (BMI of ≥30 kg/m 2 ). 25 Gestational weight gain was calculated as the difference between the last available weight measurement during pregnancy (measured by research staff or medical personnel) and the prepregnancy weight (as described). Gestational weight gain was categorized as less than recommended, within the recommended range, and greater than recommended as based on the 2009 Institute of Medicine guidelines. 26 In a subset of the Healthy Start cohort, inflammatory markers interleukin (IL)-6 and high-sensitivity C-reactive protein (CRPhs) were measured in maternal blood samples, collected at a median gestational age of 27 weeks. IL-6 was measured using Data on maternal education, household income, and race/ ethnicity were collected through research questionnaires. Maternal age at delivery was calculated from delivery date and maternal date of birth. Gestational age at delivery was abstracted from medical records or calculated based on the offspring delivery date and the offspring due date. Physical activity in pregnancy was measured using the Pregnancy Physical Activity Questionnaire. 27 Metabolic equivalent task values were estimated as described in detail elsewhere. 28 
Statistical Analyses
One-way ANOVA tests were used to examine differences in means and c 2 tests were used to examine differences in proportions across the prepregnancy BMI categories. Linear regression models estimated the associations of DII scores during pregnancy with IL-6 or CRP-hs in a subsample. Linear regression models examined the association between DII scores during pregnancy on birth weight (g), neonatal fat mass (g), neonatal fat-free mass (g), and neonatal adiposity (percent fat mass) as separate outcomes. A multinomial logistic regression model was used to examine simultaneously the association between DII scores during pregnancy on small-and large-for-gestational age neonates (with appropriate-for-gestational age neonates as the reference category). Interaction was assessed by introducing product terms between prepregnancy BMI or gestational weight gain with DII scores into separate models.
Covariates were identified a priori based on the literature. 9, 20 Our final models adjusted for maternal race/ethnicity (nonHispanic white, non-Hispanic black, Hispanic, other), maternal education (<high school, high school diploma, some college), household income (<$40 000, $40 001-$70 000, >$70 000, missing/do not know), smoking during pregnancy (yes, no), offspring sex, gestational age (weeks), gestational weight gain (kg), total caloric intake (kcal/day), and average energy expenditure (metabolic equivalents per week). Adjusted beta coefficients or ORs with corresponding 95% CIs were presented for our final models. An alpha level of 0.05 was used to determine statistical significance.All analyses were performed using Stata, version 14 (StataCorp LP, College Station, TX).
Results
Of the 1410 women eligible for the current analysis, 1366 women completed ≥1 dietary recall during pregnancy. Of the remaining women, we excluded 42 mothers with a prepregnancy BMI of <18.5 kg/m 2 and 24 women for neonates born at <32 weeks of gestation. Of these women, 1078 of the offspring had complete body composition measures at birth (Figure 2 ; available at www.jpeds.com). Included motherneonate dyads (n = 1078) and excluded mother-neonate dyads (n = 332) were similar with respect to maternal age at delivery, maternal race/ethnicity, prepregnancy BMI categories, and household income (results not presented). Of these women, 511 had IL-6 and CRP-hs measured in blood samples taken at 27 weeks of gestation.
Maternal and neonatal characteristics are presented in Table I . A majority of the women included in our study were classified as lean entering pregnancy (n = 580; 54%). A total of 281 women (26%) were classified as overweight and 217 women (20%) were classified as obese entering pregnancy. Women who were lean entering pregnancy were more likely to gain weight within the recommended range (P < .01). Women who were obese entering pregnancy were more likely to be Hispanic or non-Hispanic black (P < .01), to have an annual household income of <$40 000 (P < .01), and to have attended college (P < .01). Lean, overweight, and obese women were similar with respect to maternal age (P = .78) and selfreport of any smoking during pregnancy (P = .12).
The mean DII score was +0.4 with a range from −4.4 to +4.0. Women who were classified as overweight entering pregnancy consumed fewer calories than women who were lean or obese entering pregnancy (P < .01). Women who were classified as lean entering pregnancy consumed more carbohydrates (P < .01) and more total fat (P = .03) than women who were overweight or obese entering pregnancy. We did not find evidence of a difference in the consumption of protein across the prepregnancy BMI categories (P = .14). The gestational age at delivery was slightly greater among lean women as compared with overweight or obese women (P = .02).
Individual nutrients had moderate to high correlations with DII scores (Table II ; available at www.jpeds.com). Fiber, vitamin E, and magnesium contributed the most to the DII score (Spearman rank correlation coefficients of −0.87, −0.80, and −0.87, respectively). Conversely, intake of caffeine and alcohol contributed the least to the total DII score (Spearman rank correlation coefficients of −0.17 and −0.14, respectively). Total energy, protein, total fat, saturated fat, and carbohydrates were moderately associated with the DII score (Spearman rank correlation coefficients ranging from of −0.40 to −0.64). Prepregnancy BMI and gestational weight gain were weakly associated with the DII score (Spearman rank correlation coefficients of 0.18 and −0.04, respectively). The correlation coefficients among women with ≥2 dietary recalls (n = 879) were similar to the correlation coefficients among all women included in our analyses (n = 1078).
The mean IL-6 was 1.79 ± 1.61 mg/L with a range of 0.39-23.74 mg/L. Each 1-unit increase in DII score was associated with a 0.12-mg/L increase in IL-6 levels (95% CI, 0.01-0.24; P = .03), after adjustment for prepregnancy BMI, education, household income, maternal age, parity, race/ethnicity, and smoking during pregnancy. We did not detect an interaction between DII scores and prepregnancy BMI on IL-6 levels (P for interaction = .77). DII scores were not associated with CRPhs (b = 0.29, 95% CI, −0.22, 0.80; P = .27).
Although patterns were generally in the expected direction, there was limited evidence that the DII score was independently related to birth weight, neonatal fat mass, neonatal fat-free mass, or neonatal percent fat mass in the entire study population ( Table III) . The interaction between prepregnancy BMI and DII score was statistically significant for the outcomes of birth weight, fat mass, and percent fat mass. Among neonates born to obese women, each 1-unit increase in DII score was associated with increased birth weight (59 g; 95% CI, 11-111), neonatal fat mass (24 g; 95% CI, 3-44), and neonatal percent fat mass (0.5%; 95% CI, 0.0-1.0), but not neonatal fat-free mass (37 g; 95% CI, −1, 75). Among women who were obese entering pregnancy, consuming a highly proinflammatory diet (DII score of +4.0) may result in a 472-g increase neonatal birth weight and 192-g increase in neonatal fat mass as compared with consuming a highly antiinflammatory diet (DII score of −4.0). No such associations were observed among neonates born to women who were lean or overweight entering pregnancy. No interaction between gestational weight gain and the DII score was detected for the outcomes of birth weight, neonatal fat mass, neonatal fat-free mass, and neonatal percent fat mass.
There was a main effect association between the DII score for the outcome of large-for-gestational age (Table IV) . Each 1-unit increase in DII score was associated with a 40% increase in odds of a large-for-gestational age neonate (95% CI, 1.0-1.9; P = .05). The results do not support the hypothesis that an increased DII score is associated with a small-for-gestational age neonate (0.9; 95% CI, 0.8-1.1; P = .50). There was no evidence of an interaction between DII scores with prepregnancy BMI or gestational weight for the outcomes of small-or largefor-gestational age infants.
Discussion
We observed that, among women who were obese entering pregnancy, a proinflammatory diet during pregnancy was associated with increased neonatal adiposity. However, no such association was observed among neonates of lean or overweight women. Our findings support the hypothesis that a proinflammatory diet during pregnancy in the context of preexistent maternal obesity may be a risk factor that alters the risk for neonatal adiposity.
The extent to which the DII score reflects diet-induced inflammation in pregnancy has been relatively understudied. In adult men and nonpregnant women, higher DII scores are associated with increased circulation of CRP 19 and IL-6. 21 Only 1 published study has examined the association between DII Continuous variables are expressed as the mean ± standard deviation. One-way ANOVA tests were used to examine differences in means across the prepregnancy BMI categories. Categorical variables are express as proportions of column totals. c 2 tests were used to examine differences in proportions across the prepregnancy BMI categories. *Prepregnancy BMI categories were defined as follows: lean (BMI of ≥18.5 and <2 5 kg/m THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 195 scores and inflammatory markers during pregnancy. In Project Viva, Sen et al demonstrated that higher DII scores were associated with increased circulation of CRP. 20 We observed that higher DII scores were associated with increased circulation of IL-6, but not hs-CRP, at 27 weeks of gestation. The production of CRP may depend on IL-6 secretion 29 ; therefore, we speculate that the associations may depend on the timing of the cytokine measurement.
In our cohort, we demonstrate that a higher DII score during pregnancy is associated with an increase in odds of a largefor-gestational age neonate. By contrast, in the Project Viva cohort, Sen et al observed that, among women who were obese entering pregnancy, a higher DII score during pregnancy is associated with an increase in odds of a small-for-gestational age neonate. 20 There are several factors that could explain the discrepancy. Sen et al examined this association among a welleducated population with a mean DII score of −2.6 ± 1.4, indicating that many pregnant women in Project Viva consumed a relatively anti-inflammatory diet during pregnancy. 20 We reported a mean DII score of +0.4 ± 1.5, which indicates that many of the pregnant women in Healthy Start consumed a more proinflammatory diet during pregnancy. Our results may be more generalizable to the overall pregnant population in the United States, because the mean DII score observed in our study is comparable with the mean DII score previously reported among men and women who participated in the 2005-2010 National Health and Nutrition Examination Survey (+0.9 ± 1.1). 30 The discrepancy may also be 26 (−4 to 56); P = .09 7 (−6 to 19); P = .30 24 (1 to 46); P = .04 0.1 (−0.2 to 0.4); P = .49 P for interaction ‡ P = .54 P = .08 P = .87 P = .10 *Adjusted for maternal age (years), race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, other), household income (<$40 000, $40 001-$70 000, >$70 000, missing/do not know), smoking during pregnancy (yes, no), offspring sex, gestational age (weeks), total energy (kcal/day), and average energy expenditure (metabolic equivalent task per week). Models 1 and 2 additionally adjusted for gestational weight gain (kg). Models 1 and 3 additionally adjusted for prepregnancy BMI (kg/m 2 ). †The P value for interaction was determined by including an interaction term between prepregnancy BMI and DII score in linear regression models with total mass, fat mass, fat-free mass, and adiposity as separate outcomes. ‡The P value for interaction was determined by including an interaction term between gestational weight gain and DII score in linear regression models with total mass, fat mass, fat-free mass, and adiposity as separate outcomes. Model 1: all 0.9 (0.8-1.1); P = .50 1.4 (1.0-1.9); P = .05 Model 2: interaction with prepregnancy BMI Lean (n = 580) 1.1 (0.9-1.3); P = .38 1.7 (0.6-2.1); P = .61 Overweight (n = 281) 0.9 (0.7-1.2); P = .56 1.2 (0.6-2.3); P = .60 Obese (n = 217) 0.9 (0.6-1.3); P = .56 1.6 (0.7-3.2); P = .24 P for interaction ‡ P = .28 P = .36 Model 3: interaction with gestational weight gain Less than recommended (n = 228) 1.0 (0.7-1.4); P = .97 0.7 (0.1-8.0); P = .79 Within recommended range (n = 316) 1.2 (0.8-1.7); P = .33 1.7 (0.7-4.3); P = .26 More than recommended (n = 534) 0.9 (0.7-1.1); P = .29 1.3 (0.8-1.9); P = .27 P for interaction § P = .93 P = .29
*We calculated sex-specific percentiles of birth weight for gestational age by using United States national reference data. Neonatal size was defined as follows: small for gestational age (birth weight of <10th percentile for age and sex), appropriate for gestational age (birth weight of ≥10th percentile and ≤90th percentile for age and sex), and large for gestational age (birth weight of >90th percentile for age and sex). †Adjusted for maternal age (years), race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, other), household income (<$40 000, $40 001-$70 000, >$70 000, missing/do not know), smoking during pregnancy (yes, no), offspring sex, gestational age (weeks), total energy (kcal/day), and average energy expenditure (metabolic equivalent task per week). Models 1 and 2 additionally adjusted for gestational weight gain (kg). Models 1 and 3 additionally adjusted for prepregnancy BMI (kg/m 2 ). ‡The P value for interaction was determined by including an interaction term between prepregnancy BMI and DII score in the multinomial logistic regression model. §The P value for interaction was determined by including an interaction term between gestational weight gain and DII score in the multinomial logistic regression model. due to differences in the methods of dietary assessment. In Project Viva, diet was assessed using a first-trimester and second-trimester food frequency questionnaire, 20 whereas in Healthy Start, diet was measured throughout pregnancy by 24-hour recalls. Further investigation in other large, diverse birth cohorts is warranted to assess the impact of a higher DII score during pregnancy on neonatal size and adiposity.
Maternal inflammation during pregnancy is associated with increased offspring size at birth, [3] [4] [5] [6] but mechanisms remain uncertain. Both diet-induced and obesity-induced inflammation during pregnancy may play a role. Diet-induced inflammation during pregnancy may contribute to fetal fat accretion via fetal lipotoxicity 31 and/or functional changes to fetal adipose tissue of the offspring. 32, 33 Similarly, the chronic inflammatory environment induced by maternal obesity may influence fetal fat accretion by increasing glucose and lipid availability 34 or increasing the number of adipocytes among the offspring. 16, 35 The potential mechanisms responsible for the complex inter-relationships between maternal diet, obesity, inflammation, and offspring adiposity need to be further explored in mechanistic studies.
One limitation of our approach is the use of self-reported dietary intake data. The pregnant women in our study may have failed to accurately report food frequency or quantity. 36 However, a distinct advantage of Healthy Start is the use of repeated 24-hour recalls of diet to estimate the average DII score during pregnancy (range, 1-8; median, 3), which has been shown to improve the validity of dietary recalls. 37 Another limitation is the inability to establish whether inflammation specifically mediated the association between a proinflammatory diet during pregnancy and neonatal adiposity, given the smaller sample with available inflammatory biomarkers in our study. A proinflammatory diet during pregnancy may act through several biological, metabolic, or genetic mechanisms to increase neonatal adiposity. 38 Although a number of mechanisms may play a role, inflammation seems to be an important mechanism of these associations. Our results indicate that the DII was associated with greater IL-6, which supports the hypothesized effect of maternal diet on neonatal adiposity via systemic inflammation. Furthermore, our identification of statistical interaction with prepregnancy obesity supports the hypothesis that an increased inflammatory milieu during pregnancy may be a risk factor for neonatal adiposity.
One strength of our study is the ability to examine the association between DII scores during pregnancy and neonatal adiposity, incorporating a high-quality measure of neonatal body composition. Healthy Start used air displacement plethysmography, which has been shown to provide more accurate estimates of neonatal adiposity than birth weight or other indirect measures of body composition. [39] [40] [41] In conclusion, we provide evidence for an association between a proinflammatory diet during pregnancy and fetal fat accretion among women who were obese entering pregnancy. These findings suggest that consuming an antiinflammatory diet during pregnancy may ameliorate maternal obesity-induced programming of adiposity in the next generation, a hypothesis that requires future testing. ■ 
